-
Camizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial
01 Jun 2025 12:10 GMT
…
HR-positive breast cancer
Breast cancer is the second … HER2-positive, HER2-low and HER2-ultralow metastatic breast cancer, … Estrogen receptor positive breast cancers have patient specific … hormone receptor‑positive breast cancer. Breast Cancer Res. 2021; …
-
Early Switch With Camizestrant Plus Continued CDK4/6 Inhibition Nearly Doubles PFS in ESR1-Mutant, ER+/HER2– Advanced Breast Cancer
01 Jun 2025 13:07 GMT
… ER)–positive, HER2-negative advanced breast cancer, according to … hormone receptor–positive breast cancer. Although rare at … receptor–positive, HER2-negative advanced breast cancer is critical … –positive, HER2-negative metastatic breast cancer in patients …
-
Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes
01 Jun 2025 13:25 GMT
… in patients with advanced breast cancer has found that … (ER) positive, HER2 receptor-negative breast cancer, which is driven … to an experimental new breast cancer drug called camizestrant, … monitor for ER-positive breast cancer recurrence after treatment. …
-
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
01 Jun 2025 13:09 GMT
… (Reuters) -Treating breast cancer patients with AstraZeneca’s … receptor-positive, HER2-negative breast cancer resulted in a … Care and an ASCO breast cancer expert.
“When … hormone receptor-positive, HER2-negative breast cancer, the most common …
-
‘Pivotal’ new breast cancer drug can help stop tumours early
01 Jun 2025 12:59 GMT
… the growth of certain breast cancer tumours, offering hope to … “a pivotal moment in breast cancer care”.
The Serena-6 … with hormone-positive, HER2-negative breast cancer, which accounts for … “a pivotal moment in breast cancer care”.
Professor Kristian Helin, …
-
New drug can help stop certain breast cancer tumours early, trial shows
01 Jun 2025 12:13 GMT
… can help stop certain breast cancer tumours before they grow, … who had hormone-positive, HER2-negative breast cancer, which is about … “a pivotal moment in breast cancer care”.
Professor Kristian Helin, … women are diagnosed with breast cancer in the UK every …
-
'Transformational' new drug could stop breast cancer tumours before they grow, trial finds
01 Jun 2025 12:31 GMT
… drug could stop some breast cancer tumours from using hormones … from getting into the breast cancer cell, which researchers hope … with hormone-positive, HER2-negative breast cancer - about 70% of … Research UK reports that breast cancer is the most common …
-
40 Frequency of Documented IHC Score in Patients With HER2-Negative Breast Cancer in the US: An Observational Study Using Guardian Research Network Data
01 Jun 2025 03:28 GMT
… /Significance
For patients with breast cancer, HER2 expression based on immunohistochemistry (IHC … the proportion of patients with HER2-negative breast cancer who exhibit low and … 13,100 patients whose breast cancer was classified as HER2-negative; 10,746 …
-
PROs Favor Imlunestrant With/Without Abemaciclib in ER+, HER2– Breast Cancer
31 May 2025 20:57 GMT
… receptor (ER)–positive, HER2-negative advanced breast cancer who progressed after endocrine … with ER-positive, HER2-negative [advanced breast cancer],” wrote lead study … ) in patients with ER+, HER2- advanced breast cancer (ABC) treated with imlunestrant …
-
Ipatasertib Plus Fulvestrant Demonstrates Significant PFS Benefit in ER+/HER2– Metastatic Breast Cancer
01 Jun 2025 00:24 GMT
… receptor (ER)–positive, HER2-negative metastatic breast cancer following disease progression on … chair of the British Columbia Breast Tumor Group.
Exploring the Study … with] ER-positive, HER2-negative metastatic breast cancer,” Chia said in conclusion …